People

Amy Kruse

Chief Investment Officer at Satori Neuro

Signal profile Amy Kruse InvestorVC General Partner at Prime Movers lab satoricapital.comWashington, D.C.

Current affiliation: Satori Neuro · Chief Investment Officer
Investment range: $100K – $5M
Sweet spot: $1M
Investments on record: 13

Investments

$60M2026-03	Gilgamesh Pharmaceuticals	Amy Kruse
$16M2025-11	NextSense	Amy Kruse, Esther Dyson
$830K2024-04	Feel Therapeutics	Amy Kruse, Duncan Turner
$8M2024-01	TARA Mind	Amy Kruse
$19M2024-01	Motif Neurotech	Amy Kruse
$12M2023-02	Dimension Inx	Amy Kruse
$8M2023-01	Morphoceuticals	Amy Kruse
$39M2022-12	Gilgamesh Pharmaceuticals	Amy Kruse
$6M2021-11	Iridia	Amy Kruse
$12M2021-11	Cognixion	Amy Kruse
$80M2021-08	Beckley Psytech	Amy Kruse
$20M2021-07	Paradromics	Amy Kruse, Dakin Sloss
$27M2021-05	Gilgamesh Pharmaceuticals	Amy Kruse

Roles

Chief Investment Officer

Current

Board Member

Current